Quantitative PET of human urokinase-type plasminogen activator receptor with 64Cu-DOTA-AE105: implications for visualizing cancer invasion

Morten Persson, Jacob Madsen, Søren Østergaard, Mette Munk Jensen, Jesper Tranekjær Jørgensen, Karina Juhl, Charlotte Lehmann, Michael Ploug, Andreas Kjaer

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

70 Citationer (Scopus)

Abstract

Expression levels of the urokinase-type plasminogen activator receptor (uPAR) represent an established biomarker for poor prognosis in a variety of human cancers. The objective of the present study was to explore whether noninvasive PET can be used to perform a quantitative assessment of expression levels of uPAR across different human cancer xenograft models in mice and to illustrate the clinical potential of uPAR PET in future settings for individualized therapy.
OriginalsprogEngelsk
TidsskriftJournal of Nuclear Medicine
Vol/bind53
Udgave nummer1
Sider (fra-til)138-45
Antal sider8
ISSN0161-5505
DOI
StatusUdgivet - 2012

Citationsformater